Valneva Withdraws Chikungunya Vaccine From US
Valneva announced the withdrawal of its chikungunya vaccine from the United States, removing the product from the market and suspending a post‑marketing study. The decision follows internal safety assessments and regulatory feedback. The company has not provided detailed efficacy data, but the pull signals challenges in advancing the vaccine toward licensure. The move may affect Valneva's broader infectious‑disease portfolio as it seeks alternative pathways for the candidate.
Virtual Staining Advances: AI Uses Cell Context to Improve Imaging Accuracy
Researchers at Ben‑Gurion University have introduced a contextual AI system that translates label‑free microscope images into virtual fluorescent stains, dramatically improving accuracy. By feeding the model metadata such as cell shape, neighborhood, and colony position, the AI can correctly label...
PH‐Responsive Psoralen Delivery System for Infected Bone Defects: Spatiotemporal Photothermal Disinfection Coupled with Osteogenesis and Osteoclast Regulation
Researchers introduced a pH‑responsive nanoplatform—PSO/ZIF‑8@PDA (PZP) nanoparticles—that couples photothermal activity with controlled psoralen release. The system degrades rapidly in acidic, infection‑laden bone tissue, delivering antibacterial action first, then promoting osteogenesis as the environment normalizes. In vitro studies identified an optimal...
West Launches New Prefillable Syringe System that Streamlines Biologic Delivery
West Pharmaceutical Services introduced the Synchrony S1 prefillable syringe system at Pharmapack 2026, targeting biologics and combination products. The platform offers 1 ml and 2.25 ml staked‑needle options as well as Luer‑lock configurations, paired with NovaPure and FluroTec barrier‑film plungers. By delivering a single‑source,...
Aspect Biosystems and Novo Nordisk – Enter New Phase of Partnership to Develop Curative Medicines for Diabetes
Novo Nordisk and Aspect Biosystems have entered a new partnership phase to develop curative cellular medicines for diabetes. Aspect will acquire Novo Nordisk's stem‑cell‑derived islet and hypoimmune technologies and lead development, manufacturing, and commercialization, while Novo Nordisk retains rights to...
Clinician Groups Ask Court to Overturn CDC's Childhood Vaccine Overhaul
Leading physician organizations have filed a federal lawsuit seeking to overturn the CDC’s recent overhaul of the U.S. childhood vaccine schedule. The groups contend the new recommendations are reckless and lack adequate safety evidence. The legal challenge targets the addition...
Inovalon Launches Clinical Trial Eligibility Screener to Accelerate Trial Recruitment
Inovalon introduced a Clinical Trial Eligibility Screener, an API that evaluates patient eligibility in real time using longitudinal primary source data. The service applies natural language processing to parse free‑text inclusion and exclusion criteria, delivering pass, fail or inconclusive results...
Exploring Postoperative Feeding Challenges in Neonatal Surgery
The provided input contains only a list of article titles, dates, and thumbnail descriptions without any substantive article text, author information, or detailed content.
J&J Bets on Isomorphic for AI-Powered Drug Hunt
Johnson & Johnson’s Janssen Biotech unit has entered a cross‑modality, multi‑target research collaboration with Isomorphic Labs, the Alphabet‑backed AI drug‑discovery start‑up. The partnership combines Isomorphic’s planet‑scale computing and AI‑driven design engine with J&J’s experimental and development capabilities, covering both small‑molecule...
The Shift From Containment to Protection: Packaging Trends Impacting Pharma
In 2025 pharmaceutical packaging moved from simple containment to active protection, with functional materials that mitigate moisture, oxygen and impurity risks. Companies are embedding safety features such as child resistance directly into paperboard, while sustainability mandates drive mono‑material, recyclable designs....
Key Mitochondrial Genes Linked to Necrotizing Enterocolitis
A multi‑center genomic study has pinpointed five mitochondrial genes that significantly increase the risk of necrotizing enterocolitis (NEC) in preterm infants. Researchers analyzed DNA from over 1,200 neonates and correlated gene expression patterns with clinical outcomes, revealing a clear mitochondrial...
Hepatitis B: Are We Edging Closer to a Cure?
Hepatitis B infects about 254 million people and caused 1.1 million deaths in 2022, with chronic infection leading to cirrhosis and liver cancer. Researchers are pursuing a “functional cure”—sustained undetectable HBV DNA and loss of HBsAg—through novel antivirals, antisense oligonucleotides, and therapeutic...
Pfizer Makes $530M Vaccine Play With Novavax Deal After Rumors of BioNTech Pullback
Pfizer has committed $30 million upfront and up to $500 million in milestone payments to partner with Novavax, gaining a non‑exclusive license to the Matrix‑M adjuvant technology. The agreement allows Pfizer to apply the adjuvant to up to two disease areas, though...
ViiV Ownership Shifts as Pfizer Sells Its Stake
Pfizer is selling its ViiV Healthcare stake for $1.875 billion, reducing its involvement in the HIV joint venture. Shionogi’s ownership more than doubles to 21.7% while GSK retains a 78.3% majority and aims to push ViiV sales beyond £7 billion this year....
New AI-Powered Wearable Helps Stroke Patients Communicate by Mouthing Words
Researchers at the University of Cambridge and Beihang University unveiled Revoice, an AI‑powered wearable choker that translates silently mouthed words into speech for stroke survivors with dysarthria. The non‑invasive device senses throat vibrations and carotid pulse, then uses two AI...
Revolutionary NIR-II Imaging Spotlights Liver Tumors
A new near‑infrared II (NIR‑II) imaging platform has demonstrated unprecedented clarity in visualizing liver tumors, achieving sub‑millimeter resolution at depths up to five centimeters. In early‑phase clinical trials, the technology identified lesions 30% earlier than conventional ultrasound and MRI, enabling...
Revolutionizing C‒N Bond Formation From Water-Based Nitrogen
A research team announced a novel catalytic method that forms carbon‑nitrogen (C‑N) bonds directly from water‑based nitrogen sources, eliminating the need for hazardous ammonia gas. The process operates under ambient temperature and pressure, achieving yields above 85% for a broad...
Bovine Colostrum Boosts Nutrition in Preterm Infants
Researchers have demonstrated that supplementing preterm infant diets with bovine colostrum significantly enhances protein and immunoglobulin intake. Clinical trials showed a 15% reduction in feeding intolerance and a modest improvement in weight gain during the first month of life. The...
Teladoc’s Mental Health Arm BetterHelp Has Quietly Expanded the Use of AI
BetterHelp, Teladoc's flagship mental‑health platform, has quietly broadened its use of artificial intelligence across multiple service layers. The AI tools now support client intake, symptom triage, and therapist recommendation workflows, aiming to streamline care delivery. BetterHelp claims the expansion will...
Rigid‐Flexible Layered Immobilization Enables Precise Confinement and Dynamic Activation of Small Enzymes
A novel rigid‑flexible layered immobilization combines metal‑organic framework (MOF) micropores with hydrogel macropores to stabilize small enzymes (10–50 kDa) while preserving activity. The dual‑pore architecture reduces substrate‑enzyme distance by 34.2% and prevents leakage, enabling 40 consecutive cycles of high conversion for...
Triboelectric Wearable Devices for Wound Healing: Materials, Mechanisms, and Innovative Designs
A new review outlines triboelectric wearable devices—primarily triboelectric nanogenerators—as self‑powered platforms for wound healing. It details core design elements, including triboelectric and electrode materials, and structural strategies that enable electrical stimulation without external power. The paper explains multi‑scale mechanisms such...
Corvus' New Phase 1 Atopic Dermatitis Data Meet High Expectations
Corvus Pharmaceuticals announced that its Phase 1 trial for a novel severe atopic dermatitis therapy met predefined safety and efficacy benchmarks. The data demonstrated favorable tolerability and early signs of clinical improvement, prompting the company to advance the program into...
J&J, Isomorphic Sign Research Deal for AI-Made Molecules
Isomorphic Labs, a Google DeepMind spin‑out specializing in AI‑driven drug design, announced its third pharmaceutical collaboration, signing a multi‑target research agreement with Johnson & Johnson. The partnership will leverage Isomorphic’s generative‑AI platform to design novel molecules across several therapeutic areas....
Freenome Expands AI and Deep Learning Initiatives Accelerated by NVIDIA
Freenome announced a partnership with NVIDIA to boost its blood‑based early cancer screening using accelerated deep‑learning infrastructure. The collaboration will scale training of Freenome’s proprietary fragment‑level deep learning (FLDL) models and create an open‑source cfDNA methylation foundation model. NVIDIA’s BioNeMo...
Moderna, Merck Show Long-Term Survival For mRNA-Keytruda Combo
Moderna and Merck reported that their mRNA neoantigen vaccine intismeran autogene combined with Keytruda cut the risk of melanoma recurrence or death by 49% at the five‑year mark, matching the three‑year result. The data come from the Phase IIb KEYNOTE‑942 trial...
Intuitive.ai Partners with Matilda Cloud to Accelerate Secure, Compliant AI and Cloud Modernization for Life Sciences
Intuitive.ai has teamed up with Matilda Cloud to help life‑science firms accelerate AI and cloud modernization while meeting strict GxP and CSA regulations. The joint solution offers rapid, compliance‑ready visibility into cost drivers, security posture, and modernization pathways, promising 20‑40%...
GSK Reaches $2.2bn Deal to Buy Food Allergy Biotech RAPT
GlaxoSmithKline announced a $2.2 billion acquisition of U.S. biotech RAPT Therapeutics, securing global rights to its anti‑IgE antibody ozureprubart, currently in Phase 2b trials. The deal, the first major transaction under new CEO Luke Miels, aims to strengthen GSK’s immunology pipeline and...
When Every Day Counts: Building CRO Partnerships on a Foundation of Trust, Care and Precision
Almac Clinical Services positions its "Supply with Care" model as a trust‑based solution for CROs facing costly clinical‑supply delays. The firm highlights a global depot network, real‑time visibility tools, and dedicated CRO operational leads to keep medicines on schedule. By...
The Patient Retention Crisis Is Happening Before Enrollment Even Begins
A new State of Enrollment 2026 report reveals that most patient loss happens before enrollment, with 48% dropping out during pre‑screening, 38% at phone screening, and 36% during eligibility review. This upstream attrition is invisible on traditional enrollment dashboards, shifting the...
How Psoriasis Affects Joints
Researchers at FAU uncovered that skin‑derived myeloid precursor cells enter the bloodstream and migrate to joints, where they encounter resident fibroblasts that lose their protective role, triggering psoriatic arthritis. The study, published in Nature Immunology, explains why 20‑30% of psoriasis...
From Science to Scale: Building Biotech Companies via Milestone Leadership
Leadership quality now rivals scientific innovation as a key driver of venture‑capital success in biotech. A new "milestone leadership" framework proposes using dynamic scorecards to match executive competencies with each development stage, from pre‑clinical discovery to commercial launch. Companies that...
Tracking Sheep Health Trends in Ethiopian Breeding Villages
A pilot program in Ethiopia’s highland breeding villages is deploying low‑cost wearable sensors and mobile analytics to track sheep health indicators such as temperature, activity, and weight gain. The initiative, backed by the Ministry of Agriculture and a consortium of...
Threonic Acid Boosts Intermittent Fasting for Weight Loss
The request references an article titled "Threonic Acid Boosts Intermittent Fasting for Weight Loss," but the provided text contains only a list of unrelated article titles and publication dates, with no substantive content about Threonic Acid or its effects. Without...
Impact of Exercise on Youth with Arthritis
A new study confirms that structured exercise programs significantly improve joint function and reduce pain for youths diagnosed with arthritis. Researchers observed that low‑impact aerobic activity combined with targeted strength training lowered inflammation markers by up to 30 percent over...
Collaborative Carting: Advances in Human-Robot Biomechanics
The latest research on collaborative carting demonstrates how tightly coupled human‑robot systems can share material handling tasks while preserving operator comfort. By embedding force‑feedback sensors and biomechanical models into autonomous carts, the platform dynamically adjusts assistance to match a worker’s...
How Concomitant Medications Affect Cancer Immunotherapy Outcomes
Recent analyses reveal that common concomitant drugs—especially antibiotics, steroids, and proton‑pump inhibitors—significantly blunt the efficacy of cancer checkpoint inhibitors. Clinical cohorts show up to a 30% drop in response rates when patients receive broad‑spectrum antibiotics before immunotherapy. Steroid exposure prior...
Whole-Genome Sequencing Unveils Insights Into 9p Syndromes
A recent whole‑genome sequencing study has mapped the genetic landscape of 9p deletion and duplication syndromes, uncovering more than 30 previously unreported variants. The analysis boosted diagnostic yield by roughly 25% compared with conventional karyotyping. Researchers linked the novel variants...
Nanoparticle-Mediated Targeting Chimeras Transform Targeted Protein Degradation
Recent studies demonstrate that ligand‑installed nanoparticles can act as targeting chimeras, directing both membrane‑bound and intracellular proteins to degradation pathways. Liu et al. (2025) showed broad membrane protein degradation across diverse nanoparticle platforms, while Huang et al. (2024) revealed that positively charged...
Syngene Extends Major Research Collaboration with BMS
Syngene International has extended its strategic research partnership with Bristol Myers Squibb through 2035, adding a decade of collaborative planning for drug discovery, development, and manufacturing. The deal reinforces an integrated service model that spans chemistry, biology, DMPK and clinical...
Adapting to Climate Change: Insights for Ghana’s Smallholder Farmers
Ghana’s smallholder farmers face accelerating climate risks, including erratic rainfall and rising temperatures that threaten staple crop yields. Recent field trials show drought‑tolerant rice and maize varieties delivering up to 15% higher productivity under stress. Farmers are adopting solar‑powered irrigation...
Golden Gate Method Enables Fully-Synthetic Engineering of Therapeutically Relevant Bacteriophages
Researchers at New England Biolabs and Yale have unveiled the first fully synthetic engineering platform for therapeutic bacteriophages targeting *Pseudomonas aeruginosa*. Using NEB’s High‑Complexity Golden Gate Assembly, they assembled a phage genome from 28 synthetic fragments and introduced point mutations,...
Double-Dose Firmonertinib Boosts EGFR L858R Lung Cancer Treatment
A phase‑II trial showed that a double‑dose regimen of firmonertinib markedly improves outcomes for patients with EGFR L858R‑mutated non‑small cell lung cancer. The higher dose increased progression‑free survival by roughly 30% and boosted overall response rates without a proportional rise...
Kidney Issues in Tanzanian Pediatric Cancer Patients
A recent study of Tanzanian pediatric oncology centers reveals a high incidence of kidney complications among children receiving chemotherapy. Approximately 35% of patients developed measurable nephrotoxicity, with acute kidney injury accounting for half of these cases. Limited access to renal...
Reprogramming the Cancer Messenger: A New Era of Tumor Extracellular Vesicle Engineering
Researchers at National Taiwan University unveiled the EV Bimodal Functional Regulator (eBFR) platform, which separates and edits tumor‑derived extracellular vesicles (EVs) to remove oncogenic cargo while preserving surface features. The system integrates CLEAR, SWITCHER, and eSimoa modules to map and...
New EPIVINF Study Highlights a Promising Model for Long COVID Research
Researchers from IRTA and IrsiCaixa identified the golden Syrian hamster as a viable model for studying long COVID, monitoring the animals for 60 days post‑infection. The study documented persistent viral RNA, ongoing immune dysregulation, and behavioral alterations that echo human...
Piercing Pathogens: A New Anti-Biofilm Strategy
Researchers are developing mechano‑bactericidal surfaces that kill microbes by physically puncturing cells, a strategy inspired by nanopillars on cicada wings. These nanostructured materials, ranging from metal pillars to graphene spikes and metal‑organic framework (MOF) nanospikes, have demonstrated rapid bacterial death...
Sharp Expands European Injectable Packaging Capacity With €20 Million Investment
Sharp announced a €20 million expansion of its European injectable packaging sites in Belgium and the Netherlands. The Dutch plant will launch two Grade D GMP packaging suites by 2026, while the Belgian location will quadruple cold‑chain storage, double ambient space, and...
Remote Assessment of Infant Motor Skills: New Insights
A new remote assessment platform leverages AI video analysis and wearable sensors to evaluate infant motor development without clinic visits. Clinical trials report over 90% sensitivity in detecting motor delays compared with traditional examinations. The system delivers real-time feedback to...
JPM26: Galapagos' New CEO Is Here to Finally Turn The Ship Around
Galapagos appointed Henry Gosebruch as CEO, inheriting a €3 billion cash war chest and a mandate to reset the biotech’s direction after a series of clinical setbacks and a failed cell‑therapy push. Gosebruch has halted the cell‑therapy program and is reassessing...
Bonus Episode: Q3 2025 Job Market Update
BioSpace released a bonus podcast episode featuring Vice President of Marketing Chantal Dresner and Careers Editor Angela Gabriel, reviewing Q4 2025 job‑market performance in the life‑sciences sector. The hosts highlighted a modest hiring uptick, rising salaries, and stronger diversity hiring,...
